Correlation Between Petros Pharmaceuticals and Phibro Animal

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Petros Pharmaceuticals and Phibro Animal at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Petros Pharmaceuticals and Phibro Animal into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Petros Pharmaceuticals and Phibro Animal Health, you can compare the effects of market volatilities on Petros Pharmaceuticals and Phibro Animal and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Petros Pharmaceuticals with a short position of Phibro Animal. Check out your portfolio center. Please also check ongoing floating volatility patterns of Petros Pharmaceuticals and Phibro Animal.

Diversification Opportunities for Petros Pharmaceuticals and Phibro Animal

-0.4
  Correlation Coefficient

Very good diversification

The 3 months correlation between Petros and Phibro is -0.4. Overlapping area represents the amount of risk that can be diversified away by holding Petros Pharmaceuticals and Phibro Animal Health in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Phibro Animal Health and Petros Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Petros Pharmaceuticals are associated (or correlated) with Phibro Animal. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Phibro Animal Health has no effect on the direction of Petros Pharmaceuticals i.e., Petros Pharmaceuticals and Phibro Animal go up and down completely randomly.

Pair Corralation between Petros Pharmaceuticals and Phibro Animal

Given the investment horizon of 90 days Petros Pharmaceuticals is expected to generate 3.96 times more return on investment than Phibro Animal. However, Petros Pharmaceuticals is 3.96 times more volatile than Phibro Animal Health. It trades about 0.01 of its potential returns per unit of risk. Phibro Animal Health is currently generating about 0.05 per unit of risk. If you would invest  62.00  in Petros Pharmaceuticals on October 9, 2024 and sell it today you would lose (21.00) from holding Petros Pharmaceuticals or give up 33.87% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthVery Weak
Accuracy100.0%
ValuesDaily Returns

Petros Pharmaceuticals  vs.  Phibro Animal Health

 Performance 
       Timeline  
Petros Pharmaceuticals 

Risk-Adjusted Performance

6 of 100

 
Weak
 
Strong
Modest
Compared to the overall equity markets, risk-adjusted returns on investments in Petros Pharmaceuticals are ranked lower than 6 (%) of all global equities and portfolios over the last 90 days. Despite fairly unfluctuating basic indicators, Petros Pharmaceuticals demonstrated solid returns over the last few months and may actually be approaching a breakup point.
Phibro Animal Health 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Phibro Animal Health has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of rather sound technical indicators, Phibro Animal is not utilizing all of its potentials. The current stock price tumult, may contribute to shorter-term losses for the shareholders.

Petros Pharmaceuticals and Phibro Animal Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Petros Pharmaceuticals and Phibro Animal

The main advantage of trading using opposite Petros Pharmaceuticals and Phibro Animal positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Petros Pharmaceuticals position performs unexpectedly, Phibro Animal can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Phibro Animal will offset losses from the drop in Phibro Animal's long position.
The idea behind Petros Pharmaceuticals and Phibro Animal Health pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Commodity Directory module to find actively traded commodities issued by global exchanges.

Other Complementary Tools

Equity Analysis
Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities
AI Portfolio Architect
Use AI to generate optimal portfolios and find profitable investment opportunities
Price Ceiling Movement
Calculate and plot Price Ceiling Movement for different equity instruments
Pair Correlation
Compare performance and examine fundamental relationship between any two equity instruments
Equity Forecasting
Use basic forecasting models to generate price predictions and determine price momentum